InsiderTrades

Form 4 for PRLB Proto Labs Inc

Accepted 2023-02-15 00:00:00 ET · period of report 2023-02-13 · accession 0001437749-23-003513 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-02-15 2023-02-13 PRLB Schumacher Daniel CFO F - Tax $34.23 -553 13.5K -4% -$18.9K
D 2023-02-15 2023-02-14 PRLB Schumacher Daniel CFO A - Grant $0.00 +5,172 18.7K +38% $0
DM 2023-02-15 2023-02-14 PRLB Schumacher Daniel CFO A - Grant $0.00 +23.3K 9,815 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-02-13 F D 553 $34.23 13,543 D — —
2 Common Common Stock 2023-02-14 A A 5,172 $0.00 18,715 D — — (F1) Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 13, 2024, and on each February 13th thereafter until all shares subject to the award are fully vested.
3 Derivative Performance Stock Units 2023-02-14 A A 10,343 $0.00 10,343 D — · — to 2025-12-31 10,343 Common Stock (F2) Each performance stock unit represents a contingent right to receive one share of Proto Labs, Inc. common stock. The performance stock units vest upon Proto Labs, Inc. common stock achieving a specified price per share.
4 Derivative Employee Stock Option (right to buy) 2023-02-14 A A 3,135 $0.00 3,135 D $33.84 · — to 2026-02-14 3,135 Common Stock (F4) The stock option vests in full on February 13, 2024.
5 Derivative Employee Stock Option (right to buy) 2023-02-14 A A 9,815 $0.00 9,815 D $33.84 · — to 2033-02-14 9,815 Common Stock (F3) 25% of shares subject to the award will vest on February 13, 2024, and on each February 13th thereafter until all shares subject to the award are fully vested.